Codiak BioSciences, Inc. Comprehensive Income
Codiak BioSciences, Inc. reported Comprehensive Income of -$37.16 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2022-03-10
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-12-31 was $16.66M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$21.70M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$21.81M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$10.31M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$37.16M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$91.71M.
- Codiak BioSciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$77.91M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-12-31 | $16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$5.04M derived: sum of 2 quarters · filed 2022-03-10 | -$26.85M derived: sum of 3 quarters · filed 2022-03-10 | -$37.16M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$21.70M 10-Q · filed 2021-11-04 | -$43.51M derived: sum of 2 quarters · filed 2021-11-04 | -$53.82M 10-Q · filed 2021-11-04 | -$71.78M derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-06-30 | -$21.81M 10-Q · filed 2021-08-05 | -$32.12M 10-Q · filed 2021-08-05 | -$50.07M derived: sum of 3 quarters · filed 2022-03-10 | -$85.37M derived: sum of 4 quarters · filed 2022-03-10 |
| 2021-03-31 | -$10.31M 10-Q · filed 2021-05-06 | -$28.27M derived: sum of 2 quarters · filed 2022-03-10 | -$63.56M derived: sum of 3 quarters · filed 2022-03-10 | -$79.47M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-12-31 | -$17.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$53.25M derived: sum of 2 quarters · filed 2022-03-10 | -$69.17M derived: sum of 3 quarters · filed 2022-03-10 | -$91.71M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$35.29M 10-Q · filed 2021-11-04 | -$51.21M derived: sum of 2 quarters · filed 2021-11-04 | -$73.75M 10-Q · filed 2021-11-04 | -$95.41M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$15.91M 10-Q · filed 2021-08-05 | -$38.46M 10-Q · filed 2021-08-05 | -$60.12M derived: sum of 3 quarters · filed 2021-08-05 | -$80.79M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$22.54M 10-Q · filed 2021-05-06 | -$44.20M derived: sum of 2 quarters · filed 2021-05-06 | -$64.87M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$21.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$42.33M derived: sum of 2 quarters · filed 2021-03-17 | -$77.91M 10-K · filed 2021-03-17 | |
| 2019-09-30 | -$20.67M 10-Q · filed 2020-11-19 | -$56.25M 10-Q · filed 2020-11-19 |